BOYNTON BEACH, Fla. – InteliSys Health announced RxStream Dynamic Pricing, a groundbreaking, patent-pending technology that dynamically analyzes, reprices and adjudicates pharmacy claims from drug discount card programs, SuperBin’s, and Pharmacy Benefit Manager (PBM) or carrier claims in real-time, increasing pharmacy margins and consumer savings.
Could the cost of prescription drugs go up during COVID-19?
After an eventful 2019, it’s fair to say the drug pricing debate has taken a backseat in 2020 as the health industry has collectively focused its efforts to overcome a devastating pandemic.
Tech Can Solve A Stubborn Problem: Medication Adherence
Despite the healthcare ecosystem’s push for transparency, there remains a shroud of secrecy around one ubiquitous healthcare treatment tool: prescription drugs. No one — not doctors, not insurers and certainly not patients — know what they really cost.
PBMs: Maligned as Middlemen, They’re Hearing Wedding Bells
The industry has been criticized for lack of transparency—and worse. Some see ‘a ton of sense’ in the proposed mergers with insurers and retailers. Others see a risk of even higher drug prices and a need for oversight.
Drug Pricing Transparency: Can Health IT Lower Drug Pricing for Patients?
Certain practices of pharmacy benefit managers (PBMs) have helped jack up drug prices to the point where many people can no longer afford their medications.
Insurance Consolidation May Soon Include Hospitals, Create Powerhouses
Recent moves to consolidate insurance customers under one corporate structure could lead next to carriers acquiring hospital networks.
Trump forcing insurers to pass rebates to consumers won’t lower drug prices
President Trump’s recent speech about lowering drug price has been both lauded as long-overdue and derided as an overly-broad policy blueprint that lacks real action steps.
Trump’s Blueprint on Drug Price Reform Arrives; Hospitals’ Use of 340B Program Comes Under Scrutiny
The Trump administration unveiled on Friday what it had termed a bold blueprint to address ever-rising drug prices in the United States, but it was mostly a collection of modest, pro-pharmaceutical industry proposals that would nibble at the margins of the issue and likely put more fiscal pressure on hospitals.
HIT Think How e-prescribing could help lower patients’ drug prices
Prescription drug prices are higher than they should be for many patients because of certain practices of pharmacy benefit managers.
EHR CTO to EHR developers: now is the time for drug price transparency
The public debate about high drug prices has failed to address an inconvenient truth: There are huge variations in drug pricing from one pharmacy to another within the same geographical area.